These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2971080)

  • 1. The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.
    Johansen JS; Riis BJ; Hassager C; Moen M; Jacobson J; Christiansen C
    J Clin Endocrinol Metab; 1988 Oct; 67(4):701-6. PubMed ID: 2971080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
    Riis BJ; Christiansen C; Johansen JS; Jacobson J
    J Clin Endocrinol Metab; 1990 Apr; 70(4):920-4. PubMed ID: 2138631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in vitamin D metabolism during natural and medical menopause.
    Hartwell D; Riis BJ; Christiansen C
    J Clin Endocrinol Metab; 1990 Jul; 71(1):127-32. PubMed ID: 2142491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nafarelin on bone density.
    Jacobson JB
    Am J Obstet Gynecol; 1990 Feb; 162(2):591-2. PubMed ID: 2137978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bone turnover during gonadotropin-releasing hormone superagonist-induced ovulation inhibition.
    Gudmundsson JA; Ljunghall S; Bergquist C; Wide L; Nillius SJ
    J Clin Endocrinol Metab; 1987 Jul; 65(1):159-63. PubMed ID: 2953749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration.
    Taga M; Minaguchi H
    Acta Obstet Gynecol Scand; 1996 Feb; 75(2):162-5. PubMed ID: 8604604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.
    Christiansen C; Christensen MS; Larsen NE; Transbøl IB
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1124-30. PubMed ID: 7130340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.
    Finkelstein JS; Klibanski A; Schaefer EH; Hornstein MD; Schiff I; Neer RM
    N Engl J Med; 1994 Dec; 331(24):1618-23. PubMed ID: 7969342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis.
    Ylikorkala O; Nilsson CG; Hirvonen E; Viinikka L
    Gynecol Endocrinol; 1990 Dec; 4(4):251-60. PubMed ID: 2150580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
    Andreyko JL; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a gonadotropin-releasing hormone agonist on the calcium-parathyroid axis and bone turnover in women with endometriosis.
    Newhall-Perry K; Holloway L; Osburn L; Monroe SE; Heinrichs L; Henzl M; Marcus R
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):824-9. PubMed ID: 7573251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin).
    Monroe SE; Blumenfeld Z; Andreyko JL; Schriock E; Henzl MR; Jaffe RB
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1334-41. PubMed ID: 2946710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C; Riis BJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis.
    Finkelstein JS; Arnold AL
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1214-9. PubMed ID: 10199756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide contraception by inhibition of ovulation with intranasal GnRH superagonist: clinical and metabolic aspects.
    Gudmundsson JA; Bergquist C; Nillius SJ
    Prog Clin Biol Res; 1986; 225():337-51. PubMed ID: 2947248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
    Marslew U; Overgaard K; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
    Horowitz M; Wishart J; Need AG; Morris H; Philcox J; Nordin BE
    Arch Intern Med; 1987 Apr; 147(4):681-5. PubMed ID: 3827457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis.
    Välimäki M; Nilsson CG; Roine R; Ylikorkala O
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1097-103. PubMed ID: 2531153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3.
    Scharla SH; Minne HW; Waibel-Treber S; Schaible A; Lempert UG; Wüster C; Leyendecker G; Ziegler R
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1055-61. PubMed ID: 2138629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.